Consistent with a previous report demonstrating the association of multiple-hit TP53 mutations with complex karyotypes and poor outcomes in myelodysplastic syndromes25, three out of four cases with biallelic TP53 mutations in CML-BC patients revealed the existence of a complex karyotype. This evidence concerns the gene TP53 and breast cancer.